相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease
Bianca A. Trombetta et al.
PLOS ONE (2018)
Variability of biomarkers in patients with chronic heart failure and healthy controls
Wouter C. Meijers et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
BioInfra.Prot: A comprehensive proteomics workflow including data standardization, protein inference, expression analysis and data publication
Michael Turewicz et al.
JOURNAL OF BIOTECHNOLOGY (2017)
Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics
N. K. Magdalinou et al.
PARKINSONISM & RELATED DISORDERS (2017)
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
Anja Hviid Simonsen et al.
ALZHEIMERS & DEMENTIA (2017)
CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study
Ju-Hee Kang et al.
ACTA NEUROPATHOLOGICA (2016)
Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease
Matthew J. Simon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Diagnosis of Neurodegenerative Diseases: The Clinical Approach
Manuel Gomez-Rio et al.
CURRENT ALZHEIMER RESEARCH (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Protein Biomarkers in Parkinson's Disease: Focus on Cerebrospinal Fluid Markers and Synaptic Proteins
Steffen Halbgebauer et al.
MOVEMENT DISORDERS (2016)
A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology
R. W. Paterson et al.
TRANSLATIONAL PSYCHIATRY (2016)
Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas
Ilijana Begcevic et al.
CLINICAL PROTEOMICS (2016)
Cerebrospinal Fluid Biomarkers for Huntington's Disease
Lauren M. Byrne et al.
JOURNAL OF HUNTINGTONS DISEASE (2016)
A balanced view of the cerebrospinal fluid composition and functions: Focus on adult humans
Reynold Spector et al.
EXPERIMENTAL NEUROLOGY (2015)
Prediagnostic presentations of Parkinson's disease in primary care: a case-control study
Anette Schrag et al.
LANCET NEUROLOGY (2015)
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay
Wendy E. Heywood et al.
MOLECULAR NEURODEGENERATION (2015)
Disease-Modifying Strategies for Parkinson's Disease
Lorraine V. Kalia et al.
MOVEMENT DISORDERS (2015)
Cerebrospinal fluid inflammatory markers in patients with multiple sclerosis: a pilot study
Z. Matejcikova et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
Mirjana Babic et al.
CROATIAN MEDICAL JOURNAL (2014)
Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ
Juergen Cox et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Huntington disease: natural history, biomarkers and prospects for therapeutics
Christopher A. Ross et al.
NATURE REVIEWS NEUROLOGY (2014)
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM
Ann C. Kroksveen et al.
JOURNAL OF PROTEOMICS (2013)
Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis
S. Plum et al.
JOURNAL OF PROTEOMICS (2013)
Fluid biomarkers in Alzheimer's disease - current concepts
Christoffer Rosen et al.
MOLECULAR NEURODEGENERATION (2013)
Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort
Brit Mollenhauer et al.
NEUROLOGY (2013)
Detection of Patient Subgroups with Differential Expression in Omics Data: A Comprehensive Comparison of Univariate Measures
Maike Ahrens et al.
PLOS ONE (2013)
Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls
A. C. Kroksveen et al.
ACTA NEUROLOGICA SCANDINAVICA (2012)
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
Sara Hall et al.
ARCHIVES OF NEUROLOGY (2012)
Identification of SPARC-like 1 Protein as Part of a Biomarker Panel for Alzheimer's Disease in Cerebrospinal Fluid
Baharak Vafadar-Isfahani et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
More than 100,000 Detectable Peptide Species Elute in Single Shotgun Proteomics Runs but the Majority is Inaccessible to Data-Dependent LC-MS/MS
Annette Michalski et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
Juergen Cox et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
Manuel Comabella et al.
BRAIN (2010)
Quantitative Proteomics and Metabolomics Analysis of Normal Human Cerebrospinal Fluid Samples*
Marcel P. Stoop et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases
Guo Nan Yin et al.
BRAIN RESEARCH (2009)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry
Marcel P. Stoop et al.
PROTEOMICS (2008)
Identification of apolipoprotein A-II in cerebrospinal fluid of pediatric brain tumor patients by protein expression profiling
Judith M. de Bont et al.
CLINICAL CHEMISTRY (2006)
The role of biomarkers in clinical trials for Alzheimer disease
LJ Thal et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid
Y Hu et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Inherent biological variation and reference values
CG Fraser
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2004)
Dynamics of brain-derived proteins in cerebrospinal fluid
H Reiber
CLINICA CHIMICA ACTA (2001)
分享论文
